CFDB - Cystic Fibrosis DataBase

ongoing trials trial from other registries

Evaluation of probiotic effect on growth indicators and quality of life in children with Cystic Fibrosis - Status not known

Study design (if review, criteria of inclusion for studies)

Status not known - RCT

Participants

Inclusion criteria: Ages 2 to 12 years old; Cystic Fibrosis disease confirmed by sweat testing, clinical symptoms and common mutations. Exclusion criteria: Patient intolerance to the medication; A lack of parental consent; Inability of probiotic consumption because of severe disease.

Interventions

Protexin, 2 Capsules, daily, 1 Month vs placebo

Outcome measures

1. Quality of Life - Before the intervention, three months after the intervention, six months after intervention - PedsQL 4.0 questionnaire 2. Height - Before the intervention, one month after the intervention, three months after the intervention - Wall of examination room 3. Weight - Before the intervention, one month after the intervention, three months after the intervention - Standard scale 4. Head Circumference - Before the intervention, one month after the intervention, three months after the intervention - Meter 5. Arm Circumference - Before the intervention, one month after the intervention, three months after the intervention - Meter 6. Number of pulmonary exacerbations - One month after the intervention, three months after the intervention - Review records of patients

Keywords: Probiotics; Immunoregulatory; pharmacological_intervention;